Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 4 subfamily F member 17 (OR4F17) is a protein coding gene that encodes an olfactory receptor, which is a member of the large G protein-coupled receptor (GPCR) superfamily[1][5]. These receptors are responsible for the recognition of odorant molecules in the nasal epithelium, initiating a neuronal response that triggers the perception of smell[1][2][3]. Like other olfactory receptors, OR4F17 has a characteristic 7-transmembrane domain structure and mediates its effects by G protein signaling[1][2][3][5]. Olfactory receptor genes constitute the largest gene family in the human genome[1][7]. OR4F17 is primarily involved in sensory signal transduction but may have broader physiological roles, as emerging studies reveal ectopic expression of olfactory receptors in non-olfactory tissues, including cancers[7]. Specific disease association for OR4F17 is limited, but it is mapped as associated with Cardiofaciocutaneous Syndrome 4[1]. There is currently no established role for OR4F17 as a therapeutic target, interacting drug, or clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 4 subfamily F member 17 (OR4F17).